The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
ESOT would like to share two recent transplant-related announcements made by the EMA. EMA consultation: iBox Scoring System in kidney transplant patients The EMA has published for public consultation a “draft qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients”.
The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In
Do you want to learn more on the ESOT Mentorship Programme before applying either as mentors or mentees? Do you have any doubts on this new opportunity for professional development? Join us at the Info Session on Tuesday 18 October at 18:30 CEST! Luca Toti, Chair of the Education Committee, and Liset Pengel, Vice-Chair, will
CareDx has developed AlloSeq cfDNA, a targeted NGS assay that relies on 202 single-nucleotide polymorphisms (SNPs) located throughout the genome to measure the dd-cfDNA in transplant recipients. The assay was designed to be fully compatible with any clinical laboratory setup and combines a streamlined workflow with a fully automated analysis software to accurately quantify dd-cfDNA in transplant recipients.
ESOT is strongly committed to principles of equity, diversity and inclusion and strives to promote such values through its education programme. Members of traditionally underrepresented and marginalized groups are particularly encouraged to apply both as mentors and as mentees.
A new course on Regenerative medicine, created by Martin Hoogduijn (Rotterdam, The Netherlands), Hanne Scholz (Oslo, Norway), and Olivier Thaunat (Lyon, France), is now available on Transplant Live, the ESOT online education platform!
We are delighted to inform you that the 13th Preparatory Course for the EBSQ Examination in Transplant Surgery is taking place on 13th and 14th October 2022 in Brussels. The course organised by the UEMS Division of Transplant Surgery covers all the topics of the EBSQ Examination in Transplant Surgery: Multi-organ retrieval Kidney transplantation Pancreas
We are delighted to inform our community that registrations are open for the Fifth virtual UEMS/BTC preparatory course for transplant coordinators and colleagues involved in the field of organ donation. For more details browse the flyer or visit the website. Further information on the Transplant Coordination UEMS European Examinations are available here.
The Swiss Transplant Cohort Study (STCS) identified 13 research priorities through focus group interviews with transplant patients. The priorities were assigned to four levels, addressing 1) individual patient level priorities such as medication taking, exercise and physical fitness, or dealing with financial pressure; 2) micro level priorities covering social interactions such as trustful relationships, person-centredness;
This guideline, from a European Society of Organ Transplantation (ESOT) working group, concerns the management of kidney transplant patients with HLA antibodies. The guideline does not include patients undergoing non-renal or multi-organ transplants, and does not consider pediatric recipients in detail.
